Showing results (21-30 of 2,894) with videos related to
Sort By:
Pageof 290
Expert Opinion on Investigational Drugs|November 20, 2002
Ongoing trials involving angiotensin-converting enzyme inhibitorsSunil Nadar, Gregory Y H LipPathophysiology of Haemostasis and Thrombosis|February 5, 2005
Virchow's triad revisited: blood constituentsIrene Chung, Gregory Y H LipExpert Opinion on Pharmacotherapy|February 3, 2025
Controversies and challenges of anticoagulation therapy in obesityThomas Salmon, Gregory Y H LipReviews in Cardiovascular Medicine|July 30, 2024
Alcohol and Atrial FibrillationStanisław Surma, Gregory Y H LipCurrent Pharmaceutical Design|January 5, 2013
Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?Nicoletta Riva, Gregory Y H LipCurrent Opinion in Investigational Drugs (London, England : 2000)|August 30, 2008
Apixaban, an oral, direct inhibitor of activated Factor XaEduard Shantsila, Gregory Y H LipExpert Review of Cardiovascular Therapy|May 11, 2007
Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapyPuneet Kakar, Gregory Y H LipAnnals of Internal Medicine|January 1, 2024
In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 moHironori Ishiguchi, Gregory Y H LipAnnals of Internal Medicine|November 6, 2023
In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomesKatarzyna Nabrdalik, Gregory Y H LipPageof 290